alpha-(3-aminopropyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile has been researched along with Coronary Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, E; Ferrari, M; Motta, A; Padrini, R; Piovan, D; Toffoli, M; Trevi, GP | 1 |
1 other study(ies) available for alpha-(3-aminopropyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile and Coronary Disease
| Article | Year |
|---|---|
Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Coronary Disease; Female; Heart Valve Diseases; Humans; Male; Mathematics; Middle Aged; Models, Biological; Myocardium; Nitriles; Verapamil | 1985 |